Market Introduction
Breast reconstruction is the surgical method of reconstructing the shape and looks of a breast, most generally in women who have had surgery to treat breast cancer. It includes autologous tissue, prosthetic implants, or a mixture of both, to reconstruct a natural-looking breast. Breast reconstruction techniques have developed over the last numerous decades, with options tailored to the individual needs of women with breast cancer.
Thus, the high prevalence of breast cancer is expected to create a significant demand for breast reconstruction in the coming years, which is further anticipated to drive the breast reconstruction market.
Countries in the Middle East have also extensively affected the socio-economic situation by the COVID–19 pandemic. However, the countries have sensibly responded to the COVID–19 pandemic to avoid the spread of disease. Similar to other countries, lockdown and social distancing were imposed, which has impaired these trends hindering access to work, regular income, fairs, payments, schools, and healthcare. Therefore, it is anticipated the nations have undergone tremendous losses and are still working to recover them. In addition, the lockdown has widely affected the non-emergency medical services in the region, which has somehow affected the aesthetic sectors. Countries like Saudi Arabia and UAE are developing as breast surgery destinations in the areas. However, they are dependent on the nations for the resources; therefore, the aesthetic industry has faced a negative impact and is expected to experience the same in the following few years.
Market Overview and Dynamics
The Breast reconstruction market in Middle East and Africa is expected to grow from US$ 25.8 million in 2021 to US$ 34.8 million by 2028; it is estimated to grow at a CAGR of 4.3% from 2021 to 2028. Key players in the breast reconstruction market are increasingly focusing on the development of new and innovative products to ease the procedure and reduce the operation time. In April 2019, Polytech Health & Aesthetics, considerable player in breast implant market received FDA approval for its textured breast implants. Also, in 2018, Johnson and Johnson received FDA approval and announced launch of its CPX4 breast tissue expander. In October 2020, GC Aesthetic launched new breast implants—PERLE. Moreover, many key players in the market are aiming to upgrade their existing products to cater to the evolving demands of healthcare providers and patients. For instance, in October 2017, MTF Biologics enhance its existing FlexHD pliable perforated acellular dermal matrix (ADM) portfolio by introducing a new larger size ADM. The product upgrades are expected to offer plastic surgeons with a convenient option to perform pre-pectoral breast reconstruction procedures. Such strategic developments are driving the breast construction market growth.
Key Market Segments
In terms of technology, the inframammary segment accounted for the largest share of the Middle East and Africa breast reconstruction market in 2020. In terms of type, the breast implants segment accounted for the largest share of the Middle East and Africa breast reconstruction market in 2020. In terms of placement, the dual plane insertion segment accounted for the largest share of the Middle East and Africa breast reconstruction market in 2020. In terms of procedure, the immediate procedures segment held a larger market share of the breast reconstruction market in 2020.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the breast reconstruction market in Middle East and Africa are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Allergan Plc, Mentor Worldwide LLC (Subsidiary of Johnson & Johnson), GC Aesthetics PLC, POLYTECH Health & Aesthetics GmbH, Establishment Labs S.A., and Groupe Sebbin SAS.
Reasons to buy report
MIDDLE EAST AND AFRICA BREAST RECONSTRUCTION MARKET SEGMENTATION
By Technology
By Type
By Placement
By Procedure
By Country
Companies Mentioned
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 25.8 Million |
| Market Size by 2028 | US$ 34.8 Million |
| CAGR (2021 - 2028) | 4.3% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Technology
|
| Regions and Countries Covered |
Middle East and Africa
|
| Market leaders and key company profiles |
|
The Middle East and Africa Breast Reconstruction Market is valued at US$ 25.8 Million in 2021, it is projected to reach US$ 34.8 Million by 2028.
As per our report Middle East and Africa Breast Reconstruction Market, the market size is valued at US$ 25.8 Million in 2021, projecting it to reach US$ 34.8 Million by 2028. This translates to a CAGR of approximately 4.3% during the forecast period.
The Middle East and Africa Breast Reconstruction Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East and Africa Breast Reconstruction Market report:
The Middle East and Africa Breast Reconstruction Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Middle East and Africa Breast Reconstruction Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Middle East and Africa Breast Reconstruction Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Middle East and Africa Breast Reconstruction Market
